The estimated Net Worth of Jean W Marstiller is at least $2.42 Milhão dollars as of 15 November 2012. Ms Marstiller owns over 400 units of Cumberland Pharmaceuticals stock worth over $595,162 and over the last 15 years she sold CPIX stock worth over $1,828,697.
Ms has made over 3 trades of the Cumberland Pharmaceuticals stock since 2010, according to the Form 4 filled with the SEC. Most recently she exercised 400 units of CPIX stock worth $1,400 on 15 November 2012.
The largest trade she's ever made was selling 153,543 units of Cumberland Pharmaceuticals stock on 7 February 2010 worth over $1,828,697. On average, Ms trades about 23,310 units every 145 days since 2010. As of 15 November 2012 she still owns at least 440,828 units of Cumberland Pharmaceuticals stock.
You can see the complete history of Ms Marstiller stock trades at the bottom of the page.
Jean W. Marstiller is the Sr. VP of Admin. Services & Corp. Sec. at Cumberland Pharmaceuticals.
Ms Marstiller is 71, she's been the Sr. VP of Admin. Services & Corp. Sec. of Cumberland Pharmaceuticals since . There are 4 older and 15 younger executives at Cumberland Pharmaceuticals. The oldest executive at Cumberland Pharmaceuticals Inc. is Jonathan Griggs, 85, who is the Independent Director.
Jean's mailing address filed with the SEC is 2525 WEST END AVE., SUITE 950, NASHVILLE, TN, 37203.
Over the last 15 years, insiders at Cumberland Pharmaceuticals have traded over $4,393,644 worth of Cumberland Pharmaceuticals stock and bought 265,077 units worth $1,208,228 . The most active insiders traders include Joey A Jacobs, Leo Pavliv, eThomas R Lawrence. On average, Cumberland Pharmaceuticals executives and independent directors trade stock every 29 days with the average trade being worth of $10,407. The most recent stock trade was executed by Caroline Young on 1 December 2022, trading 379 units of CPIX stock currently worth $849.
cumberland pharmaceuticals is a specialty pharmaceutical company whose mission is to acquire currently marketed and late-stage development pharmaceutical products and grow them through marketing to targeted, underserved physician segments. cumberland is dedicated to providing high quality products which address unmet medical needs.
Cumberland Pharmaceuticals executives and other stock owners filed with the SEC include: